Density. Shifting ground. Textural discord. Sharpness like glass. Resonant emptiness. Explorative improvisation, electronica sound spaces and electric beats. Released by the Craig Taborn project Junk ...
Compass Pathways has filed paperwork for a Nasdaq IPO that will tee it up to take psilocybin therapy COMP360 through midphase development. Compass is developing psilocybin, the active ingredient in ...
A synthetic form of the active ingredient in magic mushrooms has cleared an early-phase trial. The drug, Compass Pathways’ COMP360, came through the placebo-controlled phase 1 without setting off any ...
George Goldsmith is the Chairman, CEO and Co‑Founder of COMPASS Pathways (NASDAQ:CMPS). Mr. Goldsmith’s early training and experience was a multi-disciplinary blending of cognitive psychology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results